Peptide promotes new growth in injured spinal cords

May 29, 2002

New Haven, Conn. -- Yale researchers have developed a synthetic peptide that promotes new nerve fiber growth in the damaged spinal cords of laboratory rats and allows them to walk better, according to a study published Thursday in the journal Nature.

The finding could lead to the reversal of functional deficits resulting from brain and spinal cord injuries and caused by trauma and stroke, or brought about by degenerative diseases, such as multiple sclerosis.

The lead author of the study, Stephen Strittmatter, M.D., associate professor of neurology and neurobiology at Yale School of Medicine, said the study confirms which molecules block axon regeneration in the spinal cord and shows that a peptide can promote new growth. Axons are the telephone lines of the nervous system and carry a nerve impulse to a target cell.

"One of the prominent inhibitors is Nogo and we developed a way to block Nogo action with a peptide that binds to the Nogo receptor and prevents it from doing its normal job," Strittmatter said. "There is no drug used today to promote axon recovery in humans, so it is hard to predict how well this drug will work in humans."

He said the laboratory rats were administered the peptide for four weeks through a catheter inserted into the spinal canal. A number of nerve fibers did grow back and the rats were able to walk better than without the treatment.

Before moving to human trials, Strittmatter said researchers first must determine whether the synethetic peptide can promote nerve fiber growth in animals weeks and months after injury and whether the compound is effective and safe for use in humans.

"There is some reason to think that the peptide might promote growth in older injuries because some damaged nerve fibers in the brain and spinal cord just sit there," he said. "If we had some way to block these inhibitors the nerve fibers might grow back again."

The paper is the third that Strittmatter has published in Nature about this research. The first paper described the Nogo protein. The second paper detailed the receptor through which Nogo acts. This newest data demonstrates how to block the interaction and how to reverse its function pharmacologically.

The synthetic peptide Strittmatter and his colleagues developed is 40 amino acids long and acts as an inhibitor at the Nogo receptor site.
Co-researchers included Tadzia GrandPre, a graduate student, and Shuxin Li, a postdoctoral fellow.

Yale University

Related Spinal Cord Articles from Brightsurf:

Stem cells can help repair spinal cord after injury
Spinal cord injury often leads to permanent functional impairment. In a new study published in the journal Science researchers at Karolinska Institutet in Sweden show that it is possible to stimulate stem cells in the mouse spinal cord to form large amounts of new oligodendrocytes, cells that are essential to the ability of neurons to transmit signals, and thus to help repair the spinal cord after injury.

Improving treatment of spinal cord injuries
A group led by UC Riverside bioengineering professor Victor G.

Spinal cord gives bio-bots walking rhythm
Miniature biological robots are making greater strides than ever, thanks to the spinal cord directing their steps.

Co-delivery of IL-10 and NT-3 to enhance spinal cord injury repair
Spinal cord injury (SCI) creates a complex microenvironment that is not conducive to repair; growth factors are in short supply, whereas factors that inhibit regeneration are plentiful.

Locomotor engine in the spinal cord revealed
Researchers at Karolinska Institutet in Sweden have revealed a new principle of organization which explains how locomotion is coordinated in vertebrates akin to an engine with three gears.

Neurological signals from the spinal cord surprise scientists
With a study of the network between nerve and muscle cells in turtles, researchers from the University of Copenhagen have gained new insight into the way in which movements are generated and maintained.

An 'EpiPen' for spinal cord injuries
An injection of nanoparticles can prevent the body's immune system from overreacting to trauma, potentially preventing some spinal cord injuries from resulting in paralysis.

From spinal cord injury to recovery
Spinal cord injury disconnects communication between the brain and the spinal cord, disrupting control over part of the body.

Transplanting adult spinal cord tissues: A new strategy of repair spinal cord injury
Spinal cord injury repair is one of the most challenging medical problems, and no effective therapeutic methods has been developed.

Gene medication to help treat spinal cord injuries
The two-gene medication has been proven to recover motor functions in rats.

Read More: Spinal Cord News and Spinal Cord Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to